US Stock MarketDetailed Quotes

BWAY Brainsway

Watchlist
  • 9.420
  • -0.310-3.19%
Close Dec 13 16:00 ET
  • 9.420
  • 0.0000.00%
Post 20:02 ET
177.22MMarket Cap117.75P/E (TTM)

About Brainsway Company

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Company Profile

SymbolBWAY
Company NameBrainsway
Listing DateApr 17, 2019
Issue Price11.00
Founded2006
CEOMr. Hadar Levy
MarketNASDAQ
Employees106
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
AddressBynet Building,19 Hartum Street, 3rd Floor,Har Hotzvim
CityJerusalem
ProvinceJerusalem
CountryIsrael
Zip Code9777518
Phone972-2-582-4030
Websitehttp://www.brainsway.com

Company Executives

  • Name
  • Position
  • Salary
  • Hadar Levy
  • Chief Executive Officer
  • 606.00K
  • Ido Marom
  • Chief Financial Officer
  • --
  • Moria Ankri
  • Vice President of Research and Development
  • 241.00K
  • Christopher Boyer
  • Vice President of Global Marketing
  • 337.00K
  • Colleen Hanlon, PhD
  • Vice President of Medical Affairs
  • 306.00K
  • Amiram Boehm
  • Chairman of the Board
  • 147.87K
  • Dr. David Zacut
  • Vice Chairman of the Board
  • 35.79K
  • Professor Abraham Zangen
  • Director
  • 72.18K
  • Karen Sarid
  • Independent Director
  • 56.99K
  • Avner Lushi
  • Independent Director
  • 55.61K
  • Eti Mitrany
  • Independent Director
  • 58.66K
  • Yossi Ben Shalom
  • Independent Director
  • 42.12K
  • Avner Hagai
  • Independent Director
  • 43.65K
  • Dr. Yiftach Roth
  • Chief Scientist
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data